Luminex Shares Fall on Filing of Public Offering of 3.5M Shares | GenomeWeb

This article has been updated to include market reaction to the filing.

NEW YORK (GenomeWeb News) – Shares of Luminex fell nearly 10 percent today after the firm announced yesterday that it had filed a preliminary prospectus with the US Securities and Exchange Commission to offer 3.5 million shares of common stock.

Luminex's shares dropped 9.5 percent to $20.29 in late Tuesday trade on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.